Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss

Sundeep Khosla, Roberto Pacifici

Research output: Chapter in Book/Report/Conference proceedingChapter

10 Citations (Scopus)

Abstract

Estrogen deficiency is a pivotal cause of postmenopausal bone loss and contributes to age-related bone loss in both sexes. At the cellular level, estrogen acts on multiple cell types, including T cells. Estrogen deficiency is associated with increased production of tumor necrosis factor by bone marrow T cells, which augments receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis. Moreover, estrogen deficiency alters the regulatory cross-talk between T cells and stromal cells (SC), resulting in enhanced production of osteoclastogenic cytokines by SCs. Estrogen also has indirect positive effects on calcium metabolism and its deficiency reduces both intestinal and renal calcium absorption. In addition, estrogen is a major regulator of bone metabolism in men, and low estrogen levels are associated with increased fracture risk, even in the setting of normal testosterone levels. Thus, although the causes of osteoporotic fractures are multifactorial, estrogen deficiency plays a prominent role in the pathogenesis of osteoporosis in both sexes.

Original languageEnglish (US)
Title of host publicationOsteoporosis: Fourth Edition
PublisherElsevier Inc.
Pages1113-1136
Number of pages24
ISBN (Print)9780124158535
DOIs
StatePublished - Jun 2013

Fingerprint

Postmenopausal Osteoporosis
Osteoporosis
Estrogens
T-Lymphocytes
RANK Ligand
Calcium
Osteoporotic Fractures
Stromal Cells
Osteogenesis
Bone Marrow Cells
Testosterone
Tumor Necrosis Factor-alpha
Cytokines
Bone and Bones

Keywords

  • Aging
  • CD40L gene
  • Estrogen deficiency
  • Follicle stimulating hormone (FSH)
  • IL-7 receptor knockout mice
  • OVX
  • Sex steroids
  • SHBG
  • VBMD

ASJC Scopus subject areas

  • Medicine(all)
  • Dentistry(all)

Cite this

Khosla, S., & Pacifici, R. (2013). Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss. In Osteoporosis: Fourth Edition (pp. 1113-1136). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-415853-5.00046-7

Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss. / Khosla, Sundeep; Pacifici, Roberto.

Osteoporosis: Fourth Edition. Elsevier Inc., 2013. p. 1113-1136.

Research output: Chapter in Book/Report/Conference proceedingChapter

Khosla, Sundeep ; Pacifici, Roberto. / Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss. Osteoporosis: Fourth Edition. Elsevier Inc., 2013. pp. 1113-1136
@inbook{7777a819b8a044b383c5316d6cb01e98,
title = "Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss",
abstract = "Estrogen deficiency is a pivotal cause of postmenopausal bone loss and contributes to age-related bone loss in both sexes. At the cellular level, estrogen acts on multiple cell types, including T cells. Estrogen deficiency is associated with increased production of tumor necrosis factor by bone marrow T cells, which augments receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis. Moreover, estrogen deficiency alters the regulatory cross-talk between T cells and stromal cells (SC), resulting in enhanced production of osteoclastogenic cytokines by SCs. Estrogen also has indirect positive effects on calcium metabolism and its deficiency reduces both intestinal and renal calcium absorption. In addition, estrogen is a major regulator of bone metabolism in men, and low estrogen levels are associated with increased fracture risk, even in the setting of normal testosterone levels. Thus, although the causes of osteoporotic fractures are multifactorial, estrogen deficiency plays a prominent role in the pathogenesis of osteoporosis in both sexes.",
keywords = "Aging, CD40L gene, Estrogen deficiency, Follicle stimulating hormone (FSH), IL-7 receptor knockout mice, OVX, Sex steroids, SHBG, VBMD",
author = "Sundeep Khosla and Roberto Pacifici",
year = "2013",
month = "6",
doi = "10.1016/B978-0-12-415853-5.00046-7",
language = "English (US)",
isbn = "9780124158535",
pages = "1113--1136",
booktitle = "Osteoporosis: Fourth Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss

AU - Khosla, Sundeep

AU - Pacifici, Roberto

PY - 2013/6

Y1 - 2013/6

N2 - Estrogen deficiency is a pivotal cause of postmenopausal bone loss and contributes to age-related bone loss in both sexes. At the cellular level, estrogen acts on multiple cell types, including T cells. Estrogen deficiency is associated with increased production of tumor necrosis factor by bone marrow T cells, which augments receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis. Moreover, estrogen deficiency alters the regulatory cross-talk between T cells and stromal cells (SC), resulting in enhanced production of osteoclastogenic cytokines by SCs. Estrogen also has indirect positive effects on calcium metabolism and its deficiency reduces both intestinal and renal calcium absorption. In addition, estrogen is a major regulator of bone metabolism in men, and low estrogen levels are associated with increased fracture risk, even in the setting of normal testosterone levels. Thus, although the causes of osteoporotic fractures are multifactorial, estrogen deficiency plays a prominent role in the pathogenesis of osteoporosis in both sexes.

AB - Estrogen deficiency is a pivotal cause of postmenopausal bone loss and contributes to age-related bone loss in both sexes. At the cellular level, estrogen acts on multiple cell types, including T cells. Estrogen deficiency is associated with increased production of tumor necrosis factor by bone marrow T cells, which augments receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis. Moreover, estrogen deficiency alters the regulatory cross-talk between T cells and stromal cells (SC), resulting in enhanced production of osteoclastogenic cytokines by SCs. Estrogen also has indirect positive effects on calcium metabolism and its deficiency reduces both intestinal and renal calcium absorption. In addition, estrogen is a major regulator of bone metabolism in men, and low estrogen levels are associated with increased fracture risk, even in the setting of normal testosterone levels. Thus, although the causes of osteoporotic fractures are multifactorial, estrogen deficiency plays a prominent role in the pathogenesis of osteoporosis in both sexes.

KW - Aging

KW - CD40L gene

KW - Estrogen deficiency

KW - Follicle stimulating hormone (FSH)

KW - IL-7 receptor knockout mice

KW - OVX

KW - Sex steroids

KW - SHBG

KW - VBMD

UR - http://www.scopus.com/inward/record.url?scp=84903035841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903035841&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-415853-5.00046-7

DO - 10.1016/B978-0-12-415853-5.00046-7

M3 - Chapter

AN - SCOPUS:84903035841

SN - 9780124158535

SP - 1113

EP - 1136

BT - Osteoporosis: Fourth Edition

PB - Elsevier Inc.

ER -